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Background: Obesity-induced chronic inflammation plays a fundamental role in the pathogenesis of metabolic
syndrome (MS). Recently, a growing body of evidence supports that miRNAs are largely dysregulated in obesity
and that specific miRNAs regulate obesity-associated inflammation. We applied an approach aiming to identify
active miRNA-TF-gene regulatory pathways in obesity. Firstly, we detected differentially expressed genes (DEGs)
and differentially expressed miRNAs (DEmiRs) from mRNA and miRNA expression profiles, respectively. Secondly, by
mapping the DEGs and DEmiRs to the curated miRNA-TF-gene regulatory network as active seed nodes and connect
them with their immediate neighbors, we obtained the potential active miRNA-TF-gene regulatory subnetwork in
obesity. Thirdly, using a Breadth-First-Search (BFS) algorithm, we identified potential active miRNA-TF-gene regulatory
pathways in obesity. Finally, through the hypergeometric test, we identified the active miRNA-TF-gene regulatory
pathways that were significantly related to obesity.
Results: The potential active pathways with FDR < 0.0005 were considered to be the active miRNA-TF regulatory
pathways in obesity. The union of the active pathways is visualized and identical nodes of the active pathways
were merged.
Conclusions: We identified 23 active miRNA-TF-gene regulatory pathways that were significantly related to
obesity-related inflammation.
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The prevalence of obesity has increased drastically
worldwide. Overweight represents major health burdens
and is associated with a cluster of metabolic disorders,
such as insulin resistence and cardiovascular disease [1].
Obesity is associated with a low-grade inflammation,
which influences adipocyte function and may promote
type 2 diabetes and MS [2,3].
Adipocytes and infiltrating inflammatory cells located
within the adipose tissue (AT) secrete a number of bio-
active molecules, such as tumor necrosis fator-α (TNF-α),
interleukin (IL)-6 and adiponectin collectively called adi-
pokines. They are labeled as anti-inflammatory or pre-* Correspondence: ximei1119@126.com
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unless otherwise stated.inflammatory adipokines [4,5]. Obesity frequently leads to
a dysregulation of adipokine secretion [6,7]. However, the
mechanisms controlling adipokines production in obesity
are not clear.
In recent years, a lot of evidence has highlighted the
modulating roles of miRNAs in inflammatory system
[8,9]. MiRNAs may act directly on the target genes or
indirectly by first regulating transcription factors (TFs),
which then control the expression of genes [9]. The role
of miRNAs in adipose inflammation and obesity is still
not fully settled. Thus, integrated analysis of transcrip-
tional and post- transcriptional regulation could provide
a comprehensive regulatory map for the mechanism
study of the AT inflammation in obesity.
In this study, by using hypergeometric test we found
23 active post-transcriptional regulatory pathways in
obesity based on obesity-related mRNA and miRNA ex-
pression profiles.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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We applied a novel approach to identify active miRNA-
TF regulatory pathways in obesity. Firstly, we found dif-
ferentially expressed genes (DEGs) and differentially
expressed miRNAs (DEmiRs) from mRNA and miRNA
expression profiles which were derived from the Gene
Expression Omnibus (GEO) database [10]. Secondly, we
map the DEGs and DEmiRs to the curated miRNA-TF
regulatory network as active seed nodes and connect
them with their immediate neighbor. In this way, the
potential active miRNA-TF regulatory subnetworks in
obesity were obtained. Thirdly, based on a BFS algo-
rithm, we identified all of the directed acyclic paths
between 0-indegree nodes, where the indegree is 0, and
0-outdegree nodes, where the outdegree is 0. These
paths were defined as potential active miRNA-TF regula-
tory pathways in obesity. Finally, we mapped known
obesity-associated miRNAs, TFs and adipokines to poten-
tial active pathways. We identified the active miRNA-
TF-gene regulatory pathways that were significantly related
to obesity based on the hypergeometric test. An overview
of the approach is shown in Figure 1.
Obesity-related mRNA and miRNA expression profiles
The mRNA and miRNA expression profiles (GSE2508
and GSE18470) of human subcutaneous adipose wereFigure 1 Flow chart of the proposed approach. The orange nodes repr
represent target genes. The nodes with red border indicate the differential
the known obesity-associated TFs, adipokines and miRNAs, and the nodes
genes and miRNAs.downloaded from GEO database (Additional file 1:
Table S1 and Additional file 2: Table S2).
For mRNA expression profile, 20 lean and 19 obese sub-
jects were hybridized individually to Affymetrix oligo-
nucleotide arrays HG-U95A, B, C, D, and E 6 platforms.
In each platform, probe sets were mapped to Entrez Gene
IDs. We averaged the expression values of the probe sets
which corresponded to the same gene. The differentially
expressed genes were detected using Significance Analysis
of Microarrays (SAM) approach [11], and false discovery
rate (FDR) was used to correct for multiple testing. The
genes which were differentially expressed in all of 6
platforms were considered in the analysis.
For miRNA expression profile, we filtered out samples
with Type 2 Diabetes Mellitus. Then 6 lean and 13 obese
samples were kept for the further analysis. The differen-
tially expressed miRNAs were detected using SAM.
Curated TF and miRNA regulatory network
We generated TF and miRNA regulatory network by
merging miRTarBase,miRecords, TransmiR,TRANSFAC,
and TarBase [12-16]. Here, the curated human TF-genes
were derived from the TRANSFAC database. The curated
TF-miRNA regulations were derived from TransmiR
database. The curated human miRNA-gene regulations
were obtained from the union of miRecords, TarBase andesent miRNAs, the blue nodes represent TFs, and the yellow nodes
ly expressed genes and miRNAs, the nodes with purple border indicate
with yellow border indicate the known and differentially expressed
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work, we combined all of the redundant edges into a sin-
gle edge and deleted all of the self-directed edges from the
network [17].
Known obesity-associated genes and miRNAs
The known obesity-associated genes [18,19] and miRNAs
[2,20] are manually collected from published studies.
Identification of a potential active miRNA –TF regulatory
subnetwork in obesity
It was reported that some disease-related key genes could
hide among non-DE genes [21,22]. So we hypothesized that
the DEGs, DEmiRs, and their immediate neighbors in the
constructed miRNA-TF regulatory network potentially in-
duced the pathology of obesity. We generated the potential
active miRNA-TF regulatory subnetwork by mapping the
DEGs and DEmiRs into the regulatory network as active
seed nodes and connecting them with their neighbors [17].
Identification of potential active miRNA -TF regulatory
pathways in obesity
Based on the potential active miRNA-TF-gene regulatory
subnetwork, all directed acyclic paths from 0-indegreeFigure 2 The potential active miRNA-TF-gene regulatory subnetwork
represent TFs, and the green nodes represent target genes. The red bordernodes to 0-outdegree nodes were found. The gene/
miRNA with 0-indegree is located upstream of the regu-
latory pathway. The gene/miRNA with a 0-outdegree is
located downstream of the regulatory pathway. And the
upstream genes/miRNAs’ activation could cause a cas-
cade effect which results in the regulation of down-
stream gene/miRNA expression and leads to obesity
disease. In this study, we defined potential active regula-
tory pathways as the directed acyclic paths with more
than 2 nodes as, which contained at least one DE node
and no more than one non-DE node or nodes without
expression values between the two DE nodes [17].
Evaluation of potential active miRNA-TF-gene regulatory
pathways in obesity
Coverage rate (CR) of known obesity-associated genes
and miRNAs in the potential active pathway is used to
measure the strength of the relationships between the
potential active pathway and obesity. CR was calculated
according to
CR ¼ ND
NTin obesity. The orange nodes represent miRNAs, the blue nodes
indicates the differentially expressed genes and miRNAs.
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sociated genes and miRNAs in the pathway, and NT repre-
sents the total number of genes and miRNAs in the
pathway. Then, hypergeometric test were used to evaluate
the statistical significance of CR value. We further adjusted
p values for multiple testing using FDR [17].
Results
Potential active miRNA -TF regulatory subnetwork in obesity
We identified 1650 DEGs using FDR< 0.01 as threshold
and 14 DEmiRs with p-value ≤ 0.05. The transcriptional and
post-transcriptional regulations were obtained by integrating
from TRANSFAC, TransmiR, miRTarBase, miRecords and
TarBase to construct the curated miRNA-TF regulatory
network [17]. Then the DEGs and DEmiRs were mappedTable 1 Active miRNA-TF-gene regulatory pathways in obesit




A→ FLI1→ hsa-let-7a→MYC→ hsa-miR-20b→ STAT3→ B→ TNF-α
A→MYC→ hsa-miR-29b→ SP1→ TP53→ EGFR→ B→ TNF-α
A→ FLI1→ hsa-let-7a→MYC→ hsa-miR-20b→ STAT3→ B→ NFKB1
A→MYC→ hsa-miR-29b→ SP1→ TP53→ EGFR→ B→ NFKB1
C→ hsa-miR-29b→ SP1→ TNF
C→ hsa-miR-29b→ SP1→ RELA
C→ hsa-miR-22→MAX→ hsa-miR-193a
C→ hsa-miR-29b→ SP1→ RBP4
D→ FLT1→ hsa-let-7a
C→ hsa-miR-29b→ SP1→ VEGFA
C→ hsa-miR-29b→ SP1→ SERPINE1
C→ hsa-miR-29b→ SP1→ REL
C→ hsa-miR-29b→ SP1→ CCL2
D→ STAT1→ CCL2
C→ hsa-miR-29b→ SP1→ TP53
E→ TNF
E→ NFKB1
F→ FLI1→ hsa-let-7a→MYC→ hsa-miR-20b→ STAT3→ G→ TNF
F→MYC→ hsa-miR-29b→ SP1→ TP53→ EGFR→ G→ TNF
F→ FLI1→ hsa-let-7a→MYC→ hsa-miR-20b→ STAT3→ G→ NFKB1
F→MYC→ hsa-miR-29b→ SP1→ TP53→ EGFR→ G→ NFKB1
A for hsa-miR-204→ SNAI2→ hsa-miR-200c→ JAG1→ hsa-miR-145.
B for hsa-miR-21→ IL-1β→ hsa-miR-9→ ETS1.
C for SPI1→ IL1B→ hsa-miR-9→ ETS1→ has-miR-146a→ EGFR→ hsa-miR-21→ JA
hsa-miR-145→ FLI1→ hsa-let-7a→MYC.
D for SPI1→ IL1B→ hsa-miR-9→ ETS1→ TFAP2A→MYC→ hsa-miR-29b→ SP1→
EGFR→ hsa-miR-21→ JAG1→ hsa-miR-145.
E for TP63→ JAG1→ hsa-miR-145→ FLI1→ hsa-let-7a→MYC→ hsa-miR-29b→ SP
EGFR→ hsa-miR-21→ IL1B→ hsa-miR-9→ ETS1.
F for hsa-miR-124→ SNAI2→ hsa-miR-200c→ JAG1→ hsa-miR-145.
G forhsa-miR-21→ IL1B→ hsa-miR-9→ ETS1.to the curated miRNA-TF-gene regulatory network as
active seeds. We constructed the potential active miRNA-
TF-gene regulatory subnetwork by connecting all of the
active seeds with their immediate neighbors (Figure 2).
Finally, the subnetwork comprised 345 nodes and 1379
edges, in which 1661 genes and 3 miRNAs were differen-
tially expressed.
The active miRNA-TF-gene regulatory pathways in obesity
We identified all of the directed acyclic paths from
0-indegree nodes to 0-outdegree nodes in the potential ac-
tive miRNA-TF-gene regulatory subnetwork by BFS ap-
proach. As a result, 328800 paths with more than 2 nodes
were obtained, which were regarded as the potential active
miRNA-TF regulatory pathways in obesity. These pathwaysy
ber of known AD
s and miRNAs
Pathway length CR value p-value FDR
3 3 1 0 0
3 3 1 0 0
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
8 15 0.533 8.78E-10 0.000486716
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the potential active pathways ranged from 3 to 15, and the
average was 11.67.
Furthermore, we derived 34 known obesity-associated
genes, 29 TFs and 11miRNAs to evaluate the association
between the identified potential active pathways and obes-
ity. There were 41 obesity-associated genes and miRNAs
mapped in the potential active pathways. The coverage
rate (CR) of the known obesity-associated genes and miR-
NAs of the potential active pathway was used to measure
the strength of the association between the potential ac-
tive pathway and obesity. Next, we identified the signifi-
cantly active pathways using a hypergeometric test. The
potential active pathways with FDR < 0.0005 were con-
sidered to be the active miRNA-TF regulatory pathways
in obesity. As a result, we identified 23 active pathways
(Table 1). The union of the 23 active pathways is visual-
ized in Figure 3, and identical nodes of the active path-
ways were merged.
Discussion
Evidence has indicated that miRNAs are largely dysregu-
lated in obesity and that specific miRNAs regulate obesity-
associated inflammation [20]. In this study, we proposed
a novel approach to identify active miRNA-TF-gene regu-
latory pathways by integrating obesity-related mRNA
and miRNA expression profiles and transcriptional and
post-transcriptional regulation. As a result, we identified
23 active miRNA-TF-gene regulatory pathways that were
significantly related to obesity.
In these 23 pathways, 6 adipokines including IL-1β,
CCL2, RBP4, VEGFA,SERPINE4 and TNF-α are in-
volved. IL-1β is regulated by TF SPI1 and has-miR-21.
The has-miR-21 is involved in the complex regulation
subnet. IL-1β is expressed in and secreted from adipose
tissue [23]. IL-1β is a proinflammatory cytokine whichFigure 3 Union of 23 active miRNA-TF-gene regulatory pathways in ohas been proposed to play a role in inflammatory pan-
creatic β-cell destruction leading to type 1diabetes [24].
Obesity is associated with a low-grade inflammatory
state in white adipose tissue (WAT). Adipocytes and in-
filtrating inflammatory cells (primarily macrophages)
present within the tissue secrete key inflammatory pro-
teins, such as TNF-a, IL-6, and CCL2/monocyte chemo-
attractant protein, and their gene expression and release
are markedly increased in obesity [4,5]. CCL2 has been
proposed to initiate adipose inflammation by attracting
inflammatory cells from the blood stream into WAT and
is essential for the development of WAT inflammation
[25-27]. The miR-126 reduces the production of CCL2
by targeting directly the 3’-UTR of CCL2, while miR-
193b inhibited indirectly the CCL2 production through
down regulating the transcription factors of CCL2
(RELB, STAT6, and ETS1) [2]. In our detected subnet,
TF STAT1 and SP1 directly regulate the expression of
CCL2, and hsa-miR-145, has- miR-29b through these 2
TFs make regulation on CCL2. VEGFA stimulates angio-
genesis in adipose tissue,SERPINE4 belongs to pro-
inflammatory adipokines, and RBP4 is associated with
insulin resistance and visceral fat distribution [18]. They
are also regulated by SP1 directly and by has- miR-29b
through SP1 indirectly. TNF-α is recognized as a multi-
functional cytokine implicated in inflammation, apop-
tosis and cell survival as well as induction of insulin
resistance [28-31]. By use of motif activity response ana-
lysis, we were able to dissect pathways linking miRNAs,
TFs, and TNF-α. The predicted network comprised sev-
eral TFs with well-characterized roles in obesity-induced
inflammation and three miRNAs that were directly or
indirectly linked to TNF-α. For one of the miRNAs, we
were able to confirm the regulatory pathways proposed
by our model. In particular, we demonstrated a signal
circuit from has-miR-193b to TNF-α either via ETS1 asbesity.
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portance since its expression was associated with TNF-α
mRNA expression. Evidence has provided that specific
miRNAs regulate the polarization of macrophages and
the expression and secretion of adipokines in WAT and
a subset of miRNAs could be packaged into adipocyte-
derived microvesicles and delivered into blood or neigh-
boring cells, probably acting as inflammatory communi-
cators between adipocytes, macrophages, and distant
cells [20]. MiRNAs are secreted into circulation in a
stable manner and correlated closely with crucial meta-
bolic parameters, the plasma miRNA profiles could
therefore be used as attractive biomarkers for the meta-
bolic syndrome (MS) [20,32,33]. However, whether the
signaling circuit established in circulation is also present
in adipocytes remains to be determined.
Taken together, our results suggest that specific miR-
NAs may be important regulators of inflammation in
human circulation through their effects on adipokines
levels. This may be mediated by indirect effects on TF
circuits. miRNAs could therefore constitute novel poten-
tial targets for treating obesity comorbidities.
Conclusions
We identified 23 active miRNA-TF-gene regulatory path-
ways that were significantly related to obesity-related
inflammation.
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